Literature DB >> 23182410

A randomized study of contingency management in cocaine-dependent patients with severe and persistent mental health disorders.

Nancy M Petry1, Sheila M Alessi, Carla J Rash.   

Abstract

BACKGROUND: Contingency management (CM) is efficacious for reducing drug use, but it has rarely been applied to patients with severe and persistent mental health problems. This study evaluated the efficacy of CM for reducing cocaine use in psychiatric patients treated at a community mental health center.
METHODS: Nineteen cocaine-dependent patients with extensive histories of mental health problems and hospitalizations were randomized to twice weekly urine sample testing with or without CM for 8 weeks. In the CM condition, patients earned the chance to win prizes for each cocaine-negative urine sample. Patients also completed an instrument assessing severity of psychiatric symptoms pre- and post-treatment.
RESULTS: Patients assigned to CM achieved a mean (standard deviation) of 2.9 (1.7) weeks of continuous cocaine abstinence versus 0.6 (1.7) weeks for patients in the testing only condition, p=.008, Cohen's effect size d=1.35. Of the 16 expected samples, 46.2% (27.5) were cocaine negative in the CM condition versus 13.8% (27.9) in the testing only condition, p=.02, d=1.17, but proportions of negative samples submitted did not differ between groups. Reductions in psychiatric symptoms were noted over time in CM, but not the testing only, condition, p=.02.
CONCLUSIONS: CM yielded benefits for enhancing durations of abstinence in dual diagnosis patients, and it also was associated with reduced psychiatric symptoms. These findings call for larger-scale and longer-term evaluations of CM in psychiatric populations.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23182410      PMCID: PMC3593793          DOI: 10.1016/j.drugalcdep.2012.10.017

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  32 in total

1.  Predicting medication noncompliance after hospital discharge among patients with schizophrenia.

Authors:  M Olfson; D Mechanic; S Hansell; C A Boyer; J Walkup; P J Weiden
Journal:  Psychiatr Serv       Date:  2000-02       Impact factor: 3.084

2.  Investigating the use of contingency management in the treatment of cocaine abuse among individuals with schizophrenia: a feasibility study.

Authors:  John M Roll; Stephen T Chermack; Joy E Chudzynski
Journal:  Psychiatry Res       Date:  2004-01-30       Impact factor: 3.222

3.  Predictors of differential response to cognitive, experiential, and self-directed psychotherapeutic procedures.

Authors:  L E Beutler; D Engle; D Mohr; R J Daldrup; J Bergan; K Meredith; W Merry
Journal:  J Consult Clin Psychol       Date:  1991-04

4.  Financial reinforcers for improving medication adherence: findings from a meta-analysis.

Authors:  Nancy M Petry; Carla J Rash; Shannon Byrne; Shehryar Ashraf; William B White
Journal:  Am J Med       Date:  2012-07-14       Impact factor: 4.965

5.  Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: a feasibility study.

Authors:  S C Sigmon; S Steingard; G J Badger; S L Anthony; S T Higgins
Journal:  Exp Clin Psychopharmacol       Date:  2000-11       Impact factor: 3.157

6.  Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder.

Authors:  K T Mueser; P R Yarnold; A S Bellack
Journal:  Acta Psychiatr Scand       Date:  1992-01       Impact factor: 6.392

7.  Community reinforcement therapy for cocaine-dependent outpatients.

Authors:  Stephen T Higgins; Stacey C Sigmon; Conrad J Wong; Sarah H Heil; Gary J Badger; Robert Donham; Robert L Dantona; Stacey Anthony
Journal:  Arch Gen Psychiatry       Date:  2003-10

8.  Criminal offending in schizophrenia over a 25-year period marked by deinstitutionalization and increasing prevalence of comorbid substance use disorders.

Authors:  Cameron Wallace; Paul E Mullen; Philip Burgess
Journal:  Am J Psychiatry       Date:  2004-04       Impact factor: 18.112

9.  Outcomes of managing disability benefits among patients with substance dependence and severe mental illness.

Authors:  Richard K Ries; Dennis G Dyck; Robert Short; Debra Srebnik; Anastasia Fisher; Katherine A Comtois
Journal:  Psychiatr Serv       Date:  2004-04       Impact factor: 3.084

10.  Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom?

Authors:  Nancy M Petry; Jacqueline Tedford; Mark Austin; Charla Nich; Kathleen M Carroll; Bruce J Rounsaville
Journal:  Addiction       Date:  2004-03       Impact factor: 6.526

View more
  14 in total

Review 1.  Contingency management treatment for substance use disorders: How far has it come, and where does it need to go?

Authors:  Nancy M Petry; Sheila M Alessi; Todd A Olmstead; Carla J Rash; Kristyn Zajac
Journal:  Psychol Addict Behav       Date:  2017-06-22

Review 2.  New developments in behavioral treatments for substance use disorders.

Authors:  Brian D Kiluk; Kathleen M Carroll
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

3.  Patients with diabetes respond well to contingency management treatment targeting alcohol and substance use.

Authors:  Kimberly N Walter; Nancy M Petry
Journal:  Psychol Health Med       Date:  2014-12-22       Impact factor: 2.423

4.  Behavioral Interventions for Individuals Dually-Diagnosed with a Severe Mental Illness and a Substance Use Disorder.

Authors:  Clara M Bradizza; Paul R Stasiewicz; Kurt H Dermen
Journal:  Curr Addict Rep       Date:  2014-12-01

5.  Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action.

Authors:  Nathalie M Rieser; Marcus Herdener; Katrin H Preller
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 6.  Psychostimulant addiction treatment.

Authors:  Karran A Phillips; David H Epstein; Kenzie L Preston
Journal:  Neuropharmacology       Date:  2014-04-12       Impact factor: 5.250

Review 7.  Psychosocial interventions for psychostimulant misuse.

Authors:  Silvia Minozzi; Rosella Saulle; Franco De Crescenzo; Laura Amato
Journal:  Cochrane Database Syst Rev       Date:  2016-09-29

Review 8.  Lost in translation? Moving contingency management and cognitive behavioral therapy into clinical practice.

Authors:  Kathleen M Carroll
Journal:  Ann N Y Acad Sci       Date:  2014-09-09       Impact factor: 5.691

Review 9.  A review of the literature on contingency management in the treatment of substance use disorders, 2009-2014.

Authors:  Danielle R Davis; Allison N Kurti; Joan M Skelly; Ryan Redner; Thomas J White; Stephen T Higgins
Journal:  Prev Med       Date:  2016-08-08       Impact factor: 4.018

10.  Psychosocial interventions for people with both severe mental illness and substance misuse.

Authors:  Glenn E Hunt; Nandi Siegfried; Kirsten Morley; Carrie Brooke-Sumner; Michelle Cleary
Journal:  Cochrane Database Syst Rev       Date:  2019-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.